Literature DB >> 30505650

Muscle and Bone Mass Loss in the Elderly Population: Advances in diagnosis and treatment.

Carlos J Padilla Colón1,2, Irma L Molina-Vicenty2,3,4, María Frontera-Rodríguez2,3, Alejandra García-Ferré2,3, Bernabejoel Ponce Rivera5, Gerardo Cintrón-Vélez2,3, Sebastián Frontera-Rodríguez2,3.   

Abstract

Aging is the result of different functional changes leading to a substantial reduction of all human capabilities. A variety of anatomical and physiological changes occur with advancing age. These changes are more evident in the elderly population. There are various methods to measure muscle and bone mass loss, but the dual X-ray absorptiometry (DXA) is considered one of the most efficient. The elderly population (65 years and older) has been increasing throughout the years. Loss of muscle mass (sarcopenia) and loss bone mass (osteopenia or osteoporosis) with advancing age, when untreated, represent a major public health problem for the elderly population and may result in loss of independence in later life. Untreated age-related sarcopenia and osteopenia/osteoporosis increase the risk for falls and fractures, making older individuals more susceptible to the development of mobility limitations or severe disabilities that ultimately affect their capacity for independence. In this review, we will discuss the muscle and bone mass loss in the elderly population and advances in diagnosis and treatment.

Entities:  

Keywords:  Osteopenia; Osteoporosis; Sarcopenia

Year:  2018        PMID: 30505650      PMCID: PMC6261527          DOI: 10.7150/jbm.23390

Source DB:  PubMed          Journal:  J Biomed (Syd)        ISSN: 2207-0001


  110 in total

1.  Predictors of skeletal muscle mass in elderly men and women.

Authors:  R N Baumgartner; D L Waters; D Gallagher; J E Morley; P J Garry
Journal:  Mech Ageing Dev       Date:  1999-03-01       Impact factor: 5.432

Review 2.  Population screening in the age of genomic medicine.

Authors:  Muin J Khoury; Linda L McCabe; Edward R B McCabe
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

Review 3.  The aging of Wolff's "law": ontogeny and responses to mechanical loading in cortical bone.

Authors:  Osbjorn M Pearson; Daniel E Lieberman
Journal:  Am J Phys Anthropol       Date:  2004       Impact factor: 2.868

Review 4.  Parathyroid hormone analogues in the treatment of osteoporosis.

Authors:  Marius E Kraenzlin; Christian Meier
Journal:  Nat Rev Endocrinol       Date:  2011-07-12       Impact factor: 43.330

5.  Growth hormone versus placebo treatment for one year in growth hormone deficient adults: increase in exercise capacity and normalization of body composition.

Authors:  J O Jørgensen; N Vahl; T B Hansen; L Thuesen; C Hagen; J S Christiansen
Journal:  Clin Endocrinol (Oxf)       Date:  1996-12       Impact factor: 3.478

6.  Prevalence of sarcopenia: the impact of different diagnostic cut-off limits.

Authors:  C Beaudart; J-Y Reginster; J Slomian; F Buckinx; M Locquet; O Bruyère
Journal:  J Musculoskelet Neuronal Interact       Date:  2014-12       Impact factor: 2.041

7.  Alcohol intake and its relationship with bone mineral density, falls, and fracture risk in older men.

Authors:  Peggy M Cawthon; Stephanie L Harrison; Elizabeth Barrett-Connor; Howard A Fink; Jane A Cauley; Cora E Lewis; Eric S Orwoll; Steven R Cummings
Journal:  J Am Geriatr Soc       Date:  2006-11       Impact factor: 5.562

8.  Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group.

Authors:  K G Saag; R Emkey; T J Schnitzer; J P Brown; F Hawkins; S Goemaere; G Thamsborg; U A Liberman; P D Delmas; M P Malice; M Czachur; A G Daifotis
Journal:  N Engl J Med       Date:  1998-07-30       Impact factor: 91.245

9.  Fracture risk and zoledronic acid therapy in men with osteoporosis.

Authors:  Steven Boonen; Jean-Yves Reginster; Jean-Marc Kaufman; Kurt Lippuner; Jose Zanchetta; Bente Langdahl; Rene Rizzoli; Stanley Lipschitz; Hans Peter Dimai; Richard Witvrouw; Erik Eriksen; Kim Brixen; Luis Russo; Frank Claessens; Philemon Papanastasiou; Oscar Antunez; Guoqin Su; Christina Bucci-Rechtweg; Josef Hruska; Elodie Incera; Dirk Vanderschueren; Eric Orwoll
Journal:  N Engl J Med       Date:  2012-11-01       Impact factor: 91.245

10.  Erratum to: Clinician's guide to prevention and treatment of osteoporosis.

Authors:  F Cosman; S J de Beur; M S LeBoff; E M Lewiecki; B Tanner; S Randall; R Lindsay
Journal:  Osteoporos Int       Date:  2015-07       Impact factor: 4.507

View more
  16 in total

1.  Synergistic Effect of Whitlockite Scaffolds Combined with Alendronate to Promote Bone Regeneration.

Authors:  Jiwoon Jeong; Jung Hee Shim; Bum Mo Koo; Young Bin Choy; Chan Yeong Heo
Journal:  Tissue Eng Regen Med       Date:  2021-12-28       Impact factor: 4.169

2.  Loss in DXA-estimated total body lean mass but not fat mass predicts incident major osteoporotic fracture and hip fracture independently from FRAX: a registry-based cohort study.

Authors:  William D Leslie; John T Schousboe; Suzanne N Morin; Patrick Martineau; Lisa M Lix; Helena Johansson; Eugene V McCloskey; Nicholas C Harvey; John A Kanis
Journal:  Arch Osteoporos       Date:  2020-06-25       Impact factor: 2.617

3.  The effect of regular resistance exercise, vitamin D, and calcium supplements on the gastrocnemius muscle in rats in the post-menopausal period: An experimental study.

Authors:  Seyedeh Zahra Hosseini Sisi; Mohammad Ali Azarbayjani; Mohammadreza Vafaeenasab; Maghsoud Peeri; Mohammadreza Dehghani
Journal:  Int J Reprod Biomed       Date:  2021-03-21

Review 4.  Safety Evaluation of Natural Drugs in Chronic Skeletal Disorders: A Literature Review of Clinical Trials in the Past 20 years.

Authors:  Dongyang Zhou; Hao Zhang; Xu Xue; Yali Tao; Sicheng Wang; Xiaoxiang Ren; Jiacan Su
Journal:  Front Pharmacol       Date:  2022-01-13       Impact factor: 5.810

Review 5.  Conductive Scaffolds for Bone Tissue Engineering: Current State and Future Outlook.

Authors:  Damion T Dixon; Cheryl T Gomillion
Journal:  J Funct Biomater       Date:  2021-12-21

6.  Bone and Lean Mass Loss and Cognitive Impairment for Healthy Elder Adults: Analysis of the Nutrition and Health Survey in Taiwan 2013-2016 and a Validation Study With Structural Equation Modeling.

Authors:  Sheng-Feng Lin; Yen-Chun Fan; Wen-Harn Pan; Chyi-Huey Bai
Journal:  Front Nutr       Date:  2021-10-13

7.  (-)-Epicatechin-Enriched Extract from Camellia sinensis Improves Regulation of Muscle Mass and Function: Results from a Randomized Controlled Trial.

Authors:  Hyeyeong Seo; Seok-Hee Lee; Yooheon Park; Hee-Seok Lee; Jeong Sup Hong; Cho Young Lim; Dong Hyeon Kim; Sung-Soo Park; Hyung Joo Suh; Ki-Bae Hong
Journal:  Antioxidants (Basel)       Date:  2021-06-25

Review 8.  Natural and Synthetic Polymers for Bone Scaffolds Optimization.

Authors:  Francesca Donnaloja; Emanuela Jacchetti; Monica Soncini; Manuela T Raimondi
Journal:  Polymers (Basel)       Date:  2020-04-14       Impact factor: 4.329

Review 9.  Exercise Dosage in Reducing the Risk of Dementia Development: Mode, Duration, and Intensity-A Narrative Review.

Authors:  Sukai Wang; Hong-Yu Liu; Yi-Chen Cheng; Chun-Hsien Su
Journal:  Int J Environ Res Public Health       Date:  2021-12-17       Impact factor: 3.390

10.  Osteosarcopenia School.

Authors:  Yannis Dionyssiotis; Konstantinos Prokopidis; Panagiotis Vorniotakis; Eleftherios Bakas
Journal:  J Frailty Sarcopenia Falls       Date:  2021-12-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.